150.17
+1.11(+0.74%)
Currency In USD
| Previous Close | 149.06 |
| Open | 147.52 |
| Day High | 150.82 |
| Day Low | 146.77 |
| 52-Week High | 182.52 |
| 52-Week Low | 102.97 |
| Volume | 761,966 |
| Average Volume | 913,114 |
| Market Cap | 8.45B |
| PE | 15,017 |
| EPS | 0.01 |
| Moving Average 50 Days | 135.97 |
| Moving Average 200 Days | 134.97 |
| Change | 1.11 |
If you invested $1000 in Repligen Corporation (RGEN) 10 years ago, it would be worth $4,313.99 as of November 04, 2025 at a share price of $150.17. Whereas If you bought $1000 worth of Repligen Corporation (RGEN) shares 5 years ago, it would be worth $803.61 as of November 04, 2025 at a share price of $150.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Repligen to Report Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Oct 15, 2025 11:30 AM GMT
Webcast and Conference Call to Be Held Tuesday, October 28, 2025, at 8:30 a.m. ETWALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial resu
Repligen Corporation to Present at Upcoming September Conferences
GlobeNewswire Inc.
Aug 22, 2025 11:30 AM GMT
WALTHAM, Mass., Aug. 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending three upcoming investor conferences. The Wells F
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
GlobeNewswire Inc.
Jul 31, 2025 11:30 AM GMT
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have entered into a strategic partnership to develop